` LINCOLN (Lincoln Pharmaceuticals Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

LINCOLN
vs
BSE Sensex 30

Over the past 12 months, LINCOLN has underperformed BSE Sensex 30, delivering a return of -8% compared to the BSE Sensex 30's 6% growth.

Stocks Performance
LINCOLN vs BSE Sensex 30

Loading

Performance Gap
LINCOLN vs BSE Sensex 30

Loading
LINCOLN
BSE Sensex 30
Difference

Performance By Year
LINCOLN vs BSE Sensex 30

Loading
LINCOLN
BSE Sensex 30
Add Stock

Competitors Performance
Lincoln Pharmaceuticals Ltd vs Peers

BSE Sensex 30
LINCOLN
LLY
JNJ
NOVO B
ROG
Add Stock

Lincoln Pharmaceuticals Ltd
Glance View

Market Cap
11.2B INR
Industry
Pharmaceuticals

Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.

LINCOLN Intrinsic Value
797.25 INR
Undervaluation 30%
Intrinsic Value
Price
Back to Top